Your institution may have access to this item. Find your institution then sign in to continue.
Title
Updated estimates of survival and cost effectiveness for imatinib versus interferon-alpha plus low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukaemia.
Authors
Reed, Shelby D; Anstrom, Kevin J; Li, Yanhong; Schulman, Kevin A
Abstract
For trials in which participants are followed beyond the main study period to assess long-term outcomes, economic evaluations conducted using short-term data should be systematically updated to reflect new information.